Modulation of Lipid Metabolism and Spiramycin Biosynthesis in Streptomyces ambofaciens Unstable Mutants

Applied and Environmental Microbiology
1999.0

Abstract

<jats:title>ABSTRACT</jats:title> <jats:p> <jats:italic>Streptomyces ambofaciens</jats:italic> is prone to genetic instability involving genomic rearrangements at the extremities of the chromosomal DNA. An amplified DNA sequence (ADS205), including an open reading frame ( <jats:italic>orfPS</jats:italic> ), is responsible for the reversible loss of spiramycin production in the mutant strain NSA205 (ADS205 <jats:sup>+</jats:sup> Spi <jats:sup>−</jats:sup> ). The product of <jats:italic>orfPS</jats:italic> is homologous to polyketide synthase systems (PKSs) involved in the biosynthesis of erythromycin and rapamycin and is overexpressed in strain NSA205 compared with the parental strain RP181110. As PKSs and fatty acid synthase systems have the same precursors, we tested the possibility that overexpression of <jats:italic>orfPS</jats:italic> also affects lipid metabolism in strain NSA205. This report focuses on comparative analysis of lipids in strain RP181110, the mutant strain NSA205, and a derivative, NSA228 (ADS205 <jats:sup>−</jats:sup> Spi <jats:sup>+</jats:sup> ). NSA205 showed a dramatically depressed lipid content consisting predominantly of phospholipids and triacylglycerols. This lipid content was globally restored in strain NSA228, which had lost ADS205. Furthermore, strains RP181110 and NSA205 presented similar phospholipid and triacylglycerol compositions. No abnormal fatty acids were detected in NSA205.

Knowledge Graph

Similar Paper

Modulation of Lipid Metabolism and Spiramycin Biosynthesis in <i>Streptomyces ambofaciens</i> Unstable Mutants
Applied and Environmental Microbiology 1999.0
An amplifiable and deletable locus of Streptomyces ambofaciens RP181110 contains a very large gene homologous to polyketide synthase genes
Microbiology 1996.0
Amplification of a particular DNA sequence in Streptomyces ambofaciens RP181110 reversibly prevents spiramycin production
Research in Microbiology 1992.0
Influence of short-chain fatty acids on the production of spiramycin by Streptomyces ambofaciens
Applied Microbiology and Biotechnology 1992.0
Selection of Streptomyces ambofaciens mutants that produce large quantities of spiramycin and determination of optimal conditions for spiramycin production
Applied and Environmental Microbiology 1990.0
Regulation of the Biosynthesis of the Macrolide Antibiotic Spiramycin in <i>Streptomyces ambofaciens</i>
Journal of Bacteriology 2010.0
Genetic and biochemical features of spiramycin biosynthesis in Streptomyces ambofaciens. Curing, protoplast regeneration and plasmid transfer.
The Journal of Antibiotics 1982.0
Resistance to macrolides, lincosamides and streptogramin type B antibiotics due to a mutation in an rRNA operon of Streptomyces ambofaciens.
The EMBO Journal 1988.0
Cloning of spiramycin biosynthetic genes and their use in constructing Streptomyces ambofaciens mutants defective in spiramycin biosynthesis
Journal of Bacteriology 1990.0
Post-PKS Tailoring Steps of the Spiramycin Macrolactone Ring in Streptomyces ambofaciens
Antimicrobial Agents and Chemotherapy 2013.0